Business, energy, technology, markets and global industry news from Business News Today

neurorehabilitation

Pharma & Biotech

How PharmAla Biotech Holdings Inc. is positioning APA-01 around traumatic brain injury and neurorehabilitation

How is PharmAla Biotech Holdings Inc. positioning APA-01 for traumatic brain injury and neurorehabilitation markets? Read the full PDN analysis.

Read More
Pharma & Biotech

Merz Therapeutics tests the long game in neurorehabilitation with XEOMIN data

Spasticity care is not one injection cycle. Merz Therapeutics is pushing XEOMIN data toward durability, dosing flexibility and patient goals.

Read More